C Thomas Caskey - Net Worth and Insider Trading

C Thomas Caskey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, C Thomas Caskey owns 2 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , and Luminex Corp (LMNX) .

Click here to see the complete history of C Thomas Caskey’s form 4 insider trades.

Insider Ownership Summary of C Thomas Caskey

Ticker	Comapny	Transaction Date	Type of Owner
LXRX	Lexicon Pharmaceuticals Inc	2003-07-10	director & Chairman of the Board
LMNX	Luminex Corp	2004-05-20	director

C Thomas Caskey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

C Thomas Caskey Ownership Network

Ownership Network List of C Thomas Caskey

No Data

Ownership Network Relation of C Thomas Caskey

C Thomas Caskey Owned Company Details

What does Lexicon Pharmaceuticals Inc do?

Who are the key executives at Lexicon Pharmaceuticals Inc?

C Thomas Caskey is the director & Chairman of the Board of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .

Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary

Over the past 18 months, C Thomas Caskey made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .

In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.

Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lexicon Pharmaceuticals Inc Insider Transactions

No Available Data

C Thomas Caskey Mailing Address

Above is the net worth, insider trading, and ownership report for C Thomas Caskey. You might contact C Thomas Caskey via mailing address: 4400 Post Oak Parkway, Suite 1400, Houston Tx 77027.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.